Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.

Companies / E••••••••• I•••

E••••••••• I•••

Stage unknownBoston, MABiotechnology
Facts
Year of incorporation
unknown
Revenue range (Form D)
Decline to Disclosesec.gov
Rounds on record
1
Disclosed raised
unknownsum of rounds with a disclosed amount only
Named investors
1
Financing history
1 rounds
  1. Aug 8, 2024
    Form D equity offering · $96.5M (form d sold) · 21 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “E••••••••• I••• filed Form D: $96,450,016 sold of $112,250,024, Biotechnology”
Investors on record
1 edges
People
2 officers, 6 directors
Timeline
2
  1. Oct 15, 2024
    E••••••••• I••• filed Form D/A: $112,250,024 sold of $112,250,024, Biotechnology
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
  2. Aug 22, 2024
    E••••••••• I••• filed Form D: $96,450,016 sold of $112,250,024, Biotechnology
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
30 observations
Every observation on this company